Chemical inhibitors of NIPSNAP2 can exert their inhibitory effects through various cellular and molecular mechanisms that are critical to the protein's function. Wortmannin and LY294002, both phosphoinositide 3-kinases (PI3K) inhibitors, can impair the PI3K/AKT signaling pathway, which is integral to a range of cellular functions including vesicle trafficking, a process where NIPSNAP2 is involved. The disruption of this pathway can lead to decreased vesicle formation and transport, thereby inhibiting the functionality of NIPSNAP2. Bafilomycin A1 and Chloroquine both target the acidification within cellular organelles such as lysosomes. Bafilomycin A1, a specific inhibitor of the vacuolar-type H+-ATPase (V-ATPase), can prevent the proper functioning of NIPSNAP2 by stopping the acidification process critical for lysosomal function, while Chloroquine raises pH levels in intracellular vesicles, disrupting endosomal-lysosomal trafficking or autophagy processes where NIPSNAP2 operates.
Additionally, Dynasore, a GTPase inhibitor, can inhibit NIPSNAP2 by blocking dynamin, thereby impairing the process of endocytosis and downstream vesicular trafficking pathways. Cytochalasin D and Latrunculin A disrupt the actin cytoskeleton, an essential component for vesicle movement and cellular transport, which is likely to inhibit NIPSNAP2 by preventing vesicle motility and positioning. Monensin, an ionophore that alters ionic gradients, inhibits intracellular transport mechanisms, affecting the ionic environment necessary for vesicle fusion and trafficking, all of which are processes NIPSNAP2 is thought to be associated with. Microtubule-targeting agents such as Colchicine, Vinblastine, and Taxol offer another spectrum of inhibition. Colchicine and Vinblastine bind to tubulin, inhibiting its polymerization into microtubules, while Paclitaxel stabilizes microtubules, preventing their disassembly. The inhibition of microtubule dynamics can disrupt the intracellular transport mechanisms upon which NIPSNAP2 relies for proper function, as microtubules are essential for vesicle transport within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is an inhibitor of phosphoinositide 3-kinases (PI3K), which can indirectly inhibit NIPSNAP2 by disrupting the PI3K/AKT signaling pathway, potentially resulting in decreased vesicle trafficking, a process where NIPSNAP2 is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is another PI3K inhibitor, which, like Wortmannin, can inhibit NIPSNAP2 by impairing the PI3K/AKT pathway, leading to disruption of vesicle formation and transport mechanisms that NIPSNAP2 may facilitate. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1 is a specific inhibitor of the vacuolar-type H+-ATPase (V-ATPase). By inhibiting V-ATPase, it can inhibit NIPSNAP2 by preventing acidification of organelles like lysosomes, where NIPSNAP2 is thought to play a role. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine raises the pH in intracellular vesicles, which can inhibit NIPSNAP2 by disrupting the protein's function in endosomal-lysosomal trafficking or autophagy processes. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Dynasore is a GTPase inhibitor that can inhibit NIPSNAP2 by blocking the function of dynamin, thereby disrupting endocytosis and vesicular trafficking pathways where NIPSNAP2 is active. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor, which can inhibit NIPSNAP2 by disrupting signal transduction pathways that may involve tyrosine kinase activity, affecting vesicular transport processes. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Cytochalasin D disrupts actin filament formation and can inhibit NIPSNAP2 by altering cytoskeletal dynamics, which are essential for vesicle movement and positioning within the cell. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Latrunculin A binds to actin monomers and inhibits polymerization. This can inhibit NIPSNAP2 function by disrupting vesicular trafficking that relies on the actin cytoskeleton. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Monensin is an ionophore that disrupts ionic gradients across membranes and can inhibit NIPSNAP2 by altering intracellular transport and the ionic environment necessary for vesicle fusion and trafficking. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Colchicine binds to tubulin and prevents its polymerization into microtubules. Inhibiting microtubule formation can inhibit NIPSNAP2 by disrupting the intracellular transport mechanisms that depend on the microtubule network. | ||||||